HomeCompareUMPIX vs JNJ

UMPIX vs JNJ: Dividend Comparison 2026

UMPIX yields 0.19% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $84.00 in total portfolio value· pulled ahead in Year 10
10 years
UMPIX
UMPIX
● Live price
0.19%
Share price
$66.98
Annual div
$0.13
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.9K
Annual income
$19.38
Full UMPIX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — UMPIX vs JNJ

📍 JNJ pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUMPIXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, UMPIX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
UMPIX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

UMPIX
Annual income on $10K today (after 15% tax)
$16.27/yr
After 10yr DRIP, annual income (after tax)
$16.47/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $687.14/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of UMPIX + JNJ for your $10,000?

UMPIX: 50%JNJ: 50%
100% JNJ50/50100% UMPIX
Portfolio after 10yr
$20.0K
Annual income
$423.58/yr
Blended yield
2.12%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

UMPIX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

UMPIX buys
0
JNJ buys
0
No recent congressional trades found for UMPIX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUMPIXJNJ
Forward yield0.19%3.36%
Annual dividend / share$0.13$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$19.9K$20.0K
Annual income after 10y$19.38$827.78
Total dividends collected$193.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: UMPIX vs JNJ ($10,000, DRIP)

YearUMPIX PortfolioUMPIX Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,719$19.14$10,676$355.77+$43.00UMPIX
2$11,489$19.17$11,407$389.39+$82.00UMPIX
3$12,312$19.20$12,198$426.53+$114.00UMPIX
4$13,193$19.23$13,056$467.62+$137.00UMPIX
5$14,136$19.26$13,987$513.12+$149.00UMPIX
6$15,145$19.29$14,998$563.56+$147.00UMPIX
7$16,224$19.31$16,098$619.52+$126.00UMPIX
8$17,379$19.34$17,295$681.69+$84.00UMPIX
9$18,615$19.36$18,599$750.82+$16.00UMPIX
10← crossover$19,938$19.38$20,022$827.78$84.00JNJ

UMPIX vs JNJ: Complete Analysis 2026

UMPIXStock

The fund invests in financial instruments that ProFund Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. It is a float-adjusted, market capitalization-weighted index of 400 U.S. operating companies and real estate investment trusts selected through a process that factors in criteria such as liquidity, price, market capitalization, financial viability and public float. The fund is non-diversified.

Full UMPIX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this UMPIX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

UMPIX vs SCHDUMPIX vs JEPIUMPIX vs OUMPIX vs KOUMPIX vs MAINUMPIX vs ABBVUMPIX vs MRKUMPIX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.